The report " Global Organ-on-Chips Market, By Organ Type (Liver, Heart, Lung, and Other Organ Types), By Application (Drug Discovery, Toxicology Research, and Other Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users), and Region - Global Forecast to 2030" Global organ-on-chips market is projected to grow to US$ 85.05Mn in 2024. The requirement of alternative for animal testing is the major propelling factor for the growth of the global market. For instance, as per the US department of agriculture around 750,000 animals were used in the experiment to know the effect of organ-on-chip on the human body. Additionally, there is a need for early detection of the drug toxicity is another driving factor for the growth of the target market. Moreover, the launch of new products and advancement in technology which is the boosting factor for the growth of the global market. Nevertheless, the increase in funding and research and development activities can create an opportunity for the development of the target market.

Key Highlights:

• In 2018, AstraZeneca and Emulate Inc. declared a strategic agreement to work on organs-on-chips technology to enhance prediction of human safety and efficacy of drug candidates.

Key Market Insights from the report:        

The global organ-on-chips market accounted for the US $85.05Mn in 2024 and is also projected to register a moderate CAGR of 33.40% over the forecast period. The market report has been segmented based on organ type, application, end-user, and region.

• By organ type, the global organ-on-chips market is segmented into the liver, heart, lung, and other organ types
• By application, the global market is classified into drug discovery, toxicology research, and other applications
• By end-user, the target market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end-users
• By region, The North America region is the dominating region in the global organ-on-chip market due to the increasing number of heart failure patients. Europe is expected to show significant growth for the development of the target market during the forecast period due to increasing organ failure cases and advancement in the technology

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Organ-on-Chips Market, By Organ Type (Liver, Heart, Lung, and Other Organ Types), By Application (Drug Discovery, Toxicology Research, and Other Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users), and by Region – global forecast till 2030

To know the upcoming trends and insights prevalent in this market, click the link below:

Links:https://prophecymarketinsights.com/market_insight/Global-OrganonChips-Market-By-Organ-4076

The prominent player operating in the global organ-on-chips market includes AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems, and TissUse GmbH

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- [email protected]